Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Components of Accrued Liabilities (Detail)

v3.21.2
Balance Sheet Components - Components of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Jun. 30, 2021
Dec. 31, 2020
Accrued Liabilities Current [Abstract]    
General and administrative $ 1,207 $ 1,577
Clinical trial related costs 1,357 1,743
Non-clinical research and manufacturing operations 2,369 4,321
Payroll related 4,108 4,908
Other accrued expenses 33 26
Total Accrued liabilities $ 9,074 $ 12,575